UK launches £400 million initiative to boost clinical trials

The UK government has unveiled a £400 million ($530 million) investment program aimed at enhancing clinical trials and accelerating access to new treatments through the country’s national healthcare provider.

The public-private collaboration will establish 18 new clinical trials hubs across the UK, designed to streamline research processes and bring cutting-edge therapies to patients more quickly.

Health Secretary Wes Streeting emphasized that this investment will “fast-track the next generation of treatments to NHS patients” and position the UK as a “global leader” in health research.